These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18560335)

  • 21. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimuli-Responsive Prodrug Chemistries for Cancer Therapy.
    Bargakshatriya R; Pramanik SK
    Chembiochem; 2023 Sep; 24(18):e202300155. PubMed ID: 37341379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.
    Vemula PK; Wiradharma N; Ankrum JA; Miranda OR; John G; Karp JM
    Curr Opin Biotechnol; 2013 Dec; 24(6):1174-82. PubMed ID: 23465753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodrugs and soft drugs.
    Stańczak A; Ferra A
    Pharmacol Rep; 2006; 58(5):599-613. PubMed ID: 17085852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is prodrug design an approach to increase water solubility?
    Sanches BMA; Ferreira EI
    Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
    Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
    J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclization-activated prodrugs.
    Gomes P; Vale N; Moreira R
    Molecules; 2007 Nov; 12(11):2484-506. PubMed ID: 18065953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodrugs - an efficient way to breach delivery and targeting barriers.
    Huttunen KM; Rautio J
    Curr Top Med Chem; 2011; 11(18):2265-87. PubMed ID: 21671868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial Prodrugs to Overcome Bacterial Resistance.
    Jubeh B; Breijyeh Z; Karaman R
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32231026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
    Ye J; Shin MC; Liang Q; He H; Yang VC
    J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation and Delivery of Tetrazine-Responsive Bioorthogonal Prodrugs.
    Wang Y; Zhang C; Wu H; Feng P
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy.
    Cavallaro G; Pitarresi G; Giammona G
    Curr Top Med Chem; 2011; 11(18):2382-9. PubMed ID: 21671863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.